1 the first two applicants are the joint proprietors of australian patent number 702106 ('the patent').
the claimed invention of the patent relates to the use of the compound known as carvedilol for the manufacture of a medicament for decreasing mortality resulting from congestive heart failure and to a method for decreasing such mortality comprising the administration of carvedilol.
murray solicitor for the respondent: freehills date of hearing: 30 and 31 january, 1 and 2 february 2007 date of judgment: 9 february 2007 austlii: copyright policy | disclaimers | privacy policy | feedback url: http://www.austlii.edu.au/au/cases/cth/fca/2007/83.html